Please login to the form below

Not currently logged in

B.1.351 variant

This page shows the latest B.1.351 variant news and features for those working in and with pharma, biotech and healthcare.

EMA begins rolling review of Sanofi, GSK’s COVID-19 vaccine

EMA begins rolling review of Sanofi, GSK’s COVID-19 vaccine

another formulation targeting the Beta or B.1.351 variant. ... Last year, Sanofi and GSK delayed the COVID-19 vaccine programme after the jointly developed candidate induced low immune responses in older adults in a phase 1/2 study.

Latest news

More from news
Approximately 1 fully matching, plus 25 partially matching documents found.

Subscribe to our email news alerts


Add my company
Four Health

Beautiful things happen when you put the right ingredients together. It’s the reason that we mix behaviour change experts with...

Latest intelligence

New Playbook Alert: Virtual Patient Engagement
Millennials: the wellness generation
Looking at the results from a global healthcare research study focusing on the patients of the future...
The problem with clinical trials (and how virtual insight-gathering can help)
While still the gold standard of research, clinical trials are often riddled with issues that limit their applicability to broader populations or delay market access....